FDA ‘to approve Pfizer booster for children 12 to 15’ as US sets record of nearly half-million Covid cases
FDA ‘to approve Pfizer booster for children 12 to 15’ as US sets record of nearly half-million Covid cases
The US Food and Drug Administration (FDA) is reportedly planning to give the greenlight to Pfizer’s booster for use on children 12 to 15 years old on Monday (Picture: Getty Images)
The US Food and Drug Administration (FDA) is reportedly planning to authorize Pfizer’s booster vaccine to be used on children 12 to 15 years old on Monday.
Regulators are also set on letting children and adults get…